"False-positive pregnancy tests in females of reproductive potential receiving lenalidomide in the United States." Leukemia & Lymphoma, 59(4), pp. 1025–1026
Potential conflict of interest
Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2017.1361030.
Additional information
Funding
Celgene Corporation10.13039/100006436This work was supported by Celgene Corporation. The authors received editorial and publishing assistance from Celgene Corporation and MediTech Media, Ltd.